BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 8751804)

  • 1. Levamisole in postoperative adjuvant immunochemotherapy for gastric cancer. A randomized controlled study of the MMC + Tegafur regimen with or without levamisole. Report I.
    Niimoto M; Hattori T; Ito I; Tamada R; Inokuchi K; Orita K; Furue H; Ogawa N; Toda T; Furusawa M
    Cancer Immunol Immunother; 1984; 18(1):13-8. PubMed ID: 6435856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized controlled study of postoperative adjuvant immunochemotherapy with Nocardia rubra cell wall skeleton (N-CWS) and Tegafur for gastric carcinoma.
    Koyama S; Ozaki A; Iwasaki Y; Sakita T; Osuga T; Watanabe A; Suzuki M; Kawasaki T; Soma T; Tabuchi T
    Cancer Immunol Immunother; 1986; 22(2):148-54. PubMed ID: 3087619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The optimal period for orally administered fluoropyrimidines as an adjuvant chemotherapy for gastric cancer--a pilot study using 5-FU tablets compared with surgical operation alone].
    Fujii M; Sakabe T; Wakabayashi K; Kochi M; Mochizuki F; Kasakura Y; Yamagata M; Noro M; Osawa T; Iwai S
    Gan To Kagaku Ryoho; 1994 Jul; 21(8):1199-208. PubMed ID: 8031162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Postoperative adjuvant chemotherapy using NCS (neocarzinostatin) and 5-FU in the treatment of gastric cancer. First report--A comparison with the 5-year survival rate of patients undergoing combined therapy with MMC and 5-FU].
    Yokomori T; Taniguchi T; Iesato H; Sakata Y; Watanabe T; Kawabe K
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3064-70. PubMed ID: 2960267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.
    Nashimoto A; Nakajima T; Furukawa H; Kitamura M; Kinoshita T; Yamamura Y; Sasako M; Kunii Y; Motohashi H; Yamamoto S;
    J Clin Oncol; 2003 Jun; 21(12):2282-7. PubMed ID: 12805327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multihospital co-operative study of post-operative adjuvant chemotherapy in the treatment of gastric cancer-(Part 3). Comparisons between tegafur and UFT. North Kyushu Co-operative Study Group for Cancer Chemotherapy].
    Arima S; Yamamoto H; Hisatsugu T; Ohkuma R; Ohsato K; Abe R; Nakamura Y; Fukuyama N; Yamanouchi A; Taira A
    Gan To Kagaku Ryoho; 1991 Mar; 18(3):443-9. PubMed ID: 1900685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-operative chemotherapy in non-curative gastrectomy for advanced gastric cancer.
    Hanazaki K; Mochizuki Y; Machida T; Yokoyama S; Sodeyama H; Sode Y; Wakabayashi M; Kawamura N; Miyazaki T
    Hepatogastroenterology; 1999; 46(26):1238-43. PubMed ID: 10370699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative clinical study of adjuvant postoperative chemotherapy (5-FU, Tegafur, 5-FU + MMC) in curatively resected cases of gastric cancer. Study Group on 5-FU Oral Adjuvant Chemotherapy in Gastric Cancer].
    Nakajima T; Miwa K; Ohmori Y; Sakabe T; Fujii M; Kajitani T
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1161-8. PubMed ID: 8751804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Overview of clinical trials on adjuvant chemotherapy for curatively resected gastric cancer].
    Sasako M; Sano T; Katai H; Okajima K; Maruyama K
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():384-94. PubMed ID: 7986119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progress in postoperative adjuvant chemotherapy in gastric cancer].
    Nakajima T; Ohta K; Ohyama S; Yamaguchi T
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2481-7. PubMed ID: 12506470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent advances is surgical adjuvant chemotherapy for colorectal cancer].
    Kodaira S; Shatari T; Nozawa K
    Gan To Kagaku Ryoho; 2000 Dec; 27(14):2201-8. PubMed ID: 11142163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current status and problem of adjuvant chemotherapy for curatively resected gastric cancer].
    Saka M; Sasako M; Katai H; Sano T
    Gan To Kagaku Ryoho; 2000 Nov; 27(13):2033-42. PubMed ID: 11103234
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.